Quest Diagnostics, Inc.

NYSE:DGX   3:59:59 PM EDT
140.98
+0.91 (+0.65%)
Business Deals, Regulatory, Community

Quest Diagnostics Granted CDC Contract To Support Covid-19 Infection And Vaccination Seroprevalence Research

Published: 03/23/2022 21:48 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Granted Cdc Contract to Support Covid-19 Infection and Vaccination Seroprevalence Research.
Quest Diagnostics Inc - Total Contract Value With All Options is Valued at Up to Approximately $19.5 Million.